GB1388796A - Diagnostic agent - Google Patents
Diagnostic agentInfo
- Publication number
- GB1388796A GB1388796A GB3466673A GB3466673A GB1388796A GB 1388796 A GB1388796 A GB 1388796A GB 3466673 A GB3466673 A GB 3466673A GB 3466673 A GB3466673 A GB 3466673A GB 1388796 A GB1388796 A GB 1388796A
- Authority
- GB
- United Kingdom
- Prior art keywords
- preparation
- july
- diagnostic
- diagnostic agent
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940039227 diagnostic agent Drugs 0.000 title abstract 2
- 239000000032 diagnostic agent Substances 0.000 title abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- -1 invert sugar Chemical compound 0.000 abstract 2
- 235000002639 sodium chloride Nutrition 0.000 abstract 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 abstract 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 abstract 1
- 229920002307 Dextran Polymers 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 235000013681 dietary sucrose Nutrition 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 abstract 1
- 229960004068 hexachlorophene Drugs 0.000 abstract 1
- 229960004903 invert sugar Drugs 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000001632 sodium acetate Substances 0.000 abstract 1
- 235000017281 sodium acetate Nutrition 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 239000001540 sodium lactate Substances 0.000 abstract 1
- 235000011088 sodium lactate Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE959472 | 1972-07-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1388796A true GB1388796A (en) | 1975-03-26 |
Family
ID=20277049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3466673A Expired GB1388796A (en) | 1972-07-21 | 1973-07-20 | Diagnostic agent |
Country Status (4)
| Country | Link |
|---|---|
| CA (1) | CA1003330A (enExample) |
| DE (1) | DE2336546C2 (enExample) |
| FR (1) | FR2193601B1 (enExample) |
| GB (1) | GB1388796A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1184032A1 (en) * | 2000-08-31 | 2002-03-06 | OctoPlus B.V. | Dextran hydrogels |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE320519T1 (de) * | 1987-12-14 | 1989-10-26 | The Boeing Co., Seattle, Wash. | Cholestyraminzusammensetzungen und verfahren zu ihrer herstellung. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3006814A (en) * | 1957-04-12 | 1961-10-31 | Abbott Lab | Stabilized dextran composition |
-
1973
- 1973-07-18 DE DE19732336546 patent/DE2336546C2/de not_active Expired
- 1973-07-19 CA CA176,847A patent/CA1003330A/en not_active Expired
- 1973-07-19 FR FR7326572A patent/FR2193601B1/fr not_active Expired
- 1973-07-20 GB GB3466673A patent/GB1388796A/en not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1184032A1 (en) * | 2000-08-31 | 2002-03-06 | OctoPlus B.V. | Dextran hydrogels |
| WO2002017884A1 (en) * | 2000-08-31 | 2002-03-07 | Octoplus B.V. | Dextran hydrogels |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2336546A1 (de) | 1974-01-31 |
| CA1003330A (en) | 1977-01-11 |
| FR2193601A1 (enExample) | 1974-02-22 |
| FR2193601B1 (enExample) | 1976-07-02 |
| DE2336546C2 (de) | 1984-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2052840A1 (en) | Lactoneotrehalose, and it's preparation and uses | |
| NO178139B (no) | Ultralyd-kontrastmiddel av gassblærer og fettsyreholdige mikropartikler | |
| JPH04503211A (ja) | 多糖類分解酵素を含有する口腔および歯の手入れ用製剤 | |
| GB1331513A (en) | Polysaccharides having an anticarcinogenic effect and a method of producing them from species of basidiomycetes | |
| IE39856B1 (en) | New amino-sugar compounds their production and their medicinal use | |
| GB1385086A (en) | Insulin product | |
| KR910011900A (ko) | 글리코펩티드 항생물질의 안정화 조성물 | |
| Knight et al. | Polysaccharide skin test antigens derived from Histoplasma capsulatum and Blastomyces dermatitidis | |
| GB1388796A (en) | Diagnostic agent | |
| GB1480175A (en) | Compositions in the form of coated tablets | |
| IE36619B1 (en) | Dental plaque reducing enzymes and their preparation | |
| US4153686A (en) | Process for the preparation of glucoproteins as well as the use thereof | |
| IE40957B1 (en) | A 4-0- ,d glucopyransyl-2-deoxystreptamine, a process for its preparing, and compositions incorporating it | |
| EP0055109A2 (en) | Anticaries composition | |
| EP0057323A2 (en) | Anticaries composition | |
| GB1422084A (en) | Dentifrice compositions | |
| JP3955652B2 (ja) | 合成アミノ糖類誘導体及びその製造方法 | |
| ES8301631A1 (es) | Un metodo para la preparacion de una formulacion farmaceutica de un antibiotico glicosidico o similar. | |
| US2669563A (en) | Bismuth salt of penicillin | |
| US2738300A (en) | Stable aqueous penicillin preparation | |
| GB1062898A (en) | Pharmaceutical compositions containing protamines | |
| Polli et al. | Complexation between hexylresorcinol and polyvinylpyrrolidone and its microbiological evaluation | |
| JPH0672883A (ja) | 栄養輸液剤 | |
| Fleming et al. | Pseudomonas Septicemla with Nodules and Bullae | |
| GB1561562A (en) | Sulphonamide-containing pharmaceutical composition and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |